endogenous signaling molecules known to cause these symptoms. It does this by inhibiting cyclooxygenase, an enzyme that catalyzes the production of prostaglandins.

It was patented in 1961 and approved for medical use in 1963. It is on the World Health Organization's List of Essential Medicines.